Lowering Drug Prices by Once Again Putting Americans First
This document is an executive order titled “Lowering Drug Prices by Once Again Putting Americans First,” signed by President Donald J. Trump in April 2025. It directs multiple federal agencies—primarily the Department of Health and Human Services (HHS), the Office of Management and Budget (OMB), the Department of Labor, and the Food and Drug Administration (FDA)—to take a series of actions intended to lower prescription drug costs for Americans. The order aims to reinvigorate earlier price-reduction efforts (including through Medicare/Medicaid, drug importation, price transparency, and curbing middlemen), while preserving incentives for innovation. It lays out specific timelines for proposed guidance, rulemaking, and studies across Medicare, Medicaid, and related programs, and asks agencies to consider reforms that could reduce costs for seniors, low-income patients, and taxpayers, while expanding competition and improving pricing transparency.
Important caveat: as an executive order, this document directs agencies to propose or implement changes within existing law and appropriations. It does not by itself create new laws; its impact depends on subsequent rulemaking, regulatory action, and any necessary statutory changes by Congress. If implemented, the order could shift how Medicare, Medicaid, and other federal programs pay for drugs, influence drug availability and prices, and affect the behavior of manufacturers, wholesalers, and middlemen.
Healthcare
Donald J. TrumpApr 15, 2025